These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 3024921

  • 1. Altered c-myc RNA metabolism in Burkitt's lymphomas and mouse plasmacytomas.
    Piechaczyk M, Bonnieu A, Eick D, Remmers E, Yang JQ, Marcu K, Jeanteur P, Blanchard JM.
    Curr Top Microbiol Immunol; 1986; 132():331-8. PubMed ID: 3024921
    [No Abstract] [Full Text] [Related]

  • 2. Sequence determinants of c-myc mRNA turn-over: influence of 3' and 5' non-coding regions.
    Bonnieu A, Piechaczyk M, Marty L, Cuny M, Blanchard JM, Fort P, Jeanteur P.
    Oncogene Res; 1988 Sep; 3(2):155-66. PubMed ID: 3226724
    [Abstract] [Full Text] [Related]

  • 3. Transcriptionally active c-myc oncogene is contained within NIARD, a DNA sequence associated with chromosome translocations in B-cell neoplasia.
    Marcu KB, Harris LJ, Stanton LW, Erikson J, Watt R, Croce CM.
    Proc Natl Acad Sci U S A; 1983 Jan; 80(2):519-23. PubMed ID: 6188153
    [Abstract] [Full Text] [Related]

  • 4. Regulation of c-myc expression by IFN in Burkitt's lymphoma cells.
    Salehzada T, Blanchard JM, Mechti N, Piechaczyk M, Dani C, Jeanteur P, Lebleu B.
    Prog Clin Biol Res; 1985 Jan; 202():211-7. PubMed ID: 3832071
    [No Abstract] [Full Text] [Related]

  • 5. Chromosome 8 breakpoint far 3' of the c-myc oncogene in a Burkitt's lymphoma 2;8 variant translocation is equivalent to the murine pvt-1 locus.
    Graham M, Adams JM.
    EMBO J; 1986 Nov; 5(11):2845-51. PubMed ID: 3024964
    [Abstract] [Full Text] [Related]

  • 6. Illegitimate recombinations between c-myc and immunoglobulin loci are remodeled by deletions in mouse plasmacytomas but not in Burkitt's lymphomas.
    Müller JR, Janz S, Potter M.
    Curr Top Microbiol Immunol; 1995 Nov; 194():425-9. PubMed ID: 7895518
    [Abstract] [Full Text] [Related]

  • 7. Sequence of the murine and human cellular myc oncogenes and two modes of myc transcription resulting from chromosome translocation in B lymphoid tumours.
    Bernard O, Cory S, Gerondakis S, Webb E, Adams JM.
    EMBO J; 1983 Nov; 2(12):2375-83. PubMed ID: 6321164
    [Abstract] [Full Text] [Related]

  • 8. Aberrant c-myc RNAs of Burkitt's lymphoma cells have longer half-lives.
    Eick D, Piechaczyk M, Henglein B, Blanchard JM, Traub B, Kofler E, Wiest S, Lenoir GM, Bornkamm GW.
    EMBO J; 1985 Dec 30; 4(13B):3717-25. PubMed ID: 3004968
    [Abstract] [Full Text] [Related]

  • 9. The block of elongation in c-myc exon 1 is abolished in Burkitt's lymphoma cell lines with variant translocation.
    Eick D, Polack A, Kofler E, Bornkamm GW.
    Oncogene; 1988 Oct 30; 3(4):397-403. PubMed ID: 3078949
    [Abstract] [Full Text] [Related]

  • 10. Cellular myc oncogene is altered by chromosome translocation to an immunoglobulin locus in murine plasmacytomas and is rearranged similarly in human Burkitt lymphomas.
    Adams JM, Gerondakis S, Webb E, Corcoran LM, Cory S.
    Proc Natl Acad Sci U S A; 1983 Apr 30; 80(7):1982-6. PubMed ID: 6572957
    [Abstract] [Full Text] [Related]

  • 11. Altered myc gene transcription and intron-induced stabilization of myc RNAs in two mouse plasmacytomas.
    Bauer SR, Piechaczyk M, Nordan RP, Owens JD, Nepveu A, Marcu KB, Mushinski JF.
    Oncogene; 1989 May 30; 4(5):615-23. PubMed ID: 2657576
    [Abstract] [Full Text] [Related]

  • 12. Identification of a locus control region in the immunoglobulin heavy-chain locus that deregulates c-myc expression in plasmacytoma and Burkitt's lymphoma cells.
    Madisen L, Groudine M.
    Genes Dev; 1994 Sep 15; 8(18):2212-26. PubMed ID: 7958890
    [Abstract] [Full Text] [Related]

  • 13. Regulation of c-fgr proto-oncogene expression in Burkitt's lymphoma cells: effect of interferon treatment and relationship to EBV status and c-myc mRNA levels.
    Sharp NA, Luscombe MJ, Clemens MJ.
    Oncogene; 1989 Aug 15; 4(8):1043-6. PubMed ID: 2548145
    [Abstract] [Full Text] [Related]

  • 14. Point mutations in the c-Myc transactivation domain are common in Burkitt's lymphoma and mouse plasmacytomas.
    Bhatia K, Huppi K, Spangler G, Siwarski D, Iyer R, Magrath I.
    Nat Genet; 1993 Sep 15; 5(1):56-61. PubMed ID: 8220424
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. A non-AUG translational initiation in c-myc exon 1 generates an N-terminally distinct protein whose synthesis is disrupted in Burkitt's lymphomas.
    Hann SR, King MW, Bentley DL, Anderson CW, Eisenman RN.
    Cell; 1988 Jan 29; 52(2):185-95. PubMed ID: 3277717
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.